Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:38PM EDT. Market open.
Loading interactive chart…
- GuruFocus.com
Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
Financial Highlights and Strategic Updates
- Business Wire
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
CAMBRIDGE, Mass., May 08, 2024--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported first quarter 2024 financial results and provided business updates.
- Business Wire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., May 06, 2024--Seres Therapeutics, Inc. (Nasdaq: MCRB) ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on May 1, 2024, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 9,367 shares of its common stock to two new employees, consisting of stock options to purchase 6,244 shares of common stock and restricted stock units ("RSUs") covering 3,123 shares of its common
© 2024 Yahoo. All rights reserved.